Thu, Feb 26, 2015, 11:57 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

YM BioSciences, Inc. Ordinary S Message Board

  • renmanaz renmanaz Dec 13, 2012 4:34 PM Flag

    I still peg the optimal deal at $575 MM which ex-cash

    puts a net cost to the acquirer at $447 MM. At $575 MM, the deal would have been worth $3.64 to shareholders and the cost to the acquirer would have amounted to $2.83 per share net after cash used as part of the transaction.

    Of course, if no one else sees the true value of this deal or chooses to pass, we will get our $ or minus arbitrage action....mosty minus.


Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.